MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cambrex Company Profile (NYSE:CBM)

Consensus Ratings for Cambrex (NYSE:CBM) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $58.75 (13.57% upside)

Analysts' Ratings History for Cambrex (NYSE:CBM)
Show:
DateFirmActionRatingPrice TargetActions
2/11/2016Singular ResearchLower Price TargetBuy$63.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/1/2016SidotiInitiated CoverageBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Longbow ResearchReiterated RatingBuy$48.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2015StephensInitiated CoverageOverweight$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Craig HallumInitiated CoverageBuy$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014First AnalysisDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Cambrex (NYSE:CBM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
4/29/2016Q116$0.34$0.50$83.61 million$94.74 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2016Q4$0.83$0.54$152.94 million$156.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q3$0.38$0.40$101.09 million$92.97 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$0.44$0.63$110.03 million$106.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2015Q115$0.23$0.29$76.01 million$78.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2015Q414$0.50$0.64$117.90 million$128.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314$0.26$0.28$94.25 million$81.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014$0.21$0.32ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2014Q214$0.28$0.35$92.70 million$98.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2014Q114$0.23$0.07$79.40 million$66.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2014Q4$0.30$0.30$95.25 million$103.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2013Q313$0.21$0.20$83.60 million$78.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013$0.26$0.10$73.70 million$61.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2013Q1 2013$0.22$0.36$76.15 million$74.58 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2013Q4 2012$0.13$0.26$68.30 million$69.93 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312$0.12$0.07$61.00 million$59.21 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2012$0.21$0.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2012$0.14$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2012$0.12$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011$0.07$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011$0.13$0.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011$0.08$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2011$0.10$0.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Cambrex (NYSE:CBM)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.25$0.25$0.25
Q2 20161$0.48$0.48$0.48
Q3 20162$0.40$0.43$0.42
Q4 20162$0.93$1.07$1.00
(Data provided by Zacks Investment Research)
Dividend History for Cambrex (NYSE:CBM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cambrex (NYSE:CBM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/8/2016William B KorbDirectorSell4,142$52.47$217,330.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016William B KorbDirectorSell8,000$51.06$408,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016Steven M KloskCEOSell14,005$49.00$686,245.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Steven M KloskCEOSell16,430$49.13$807,205.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2016William B KorbDirectorSell8,000$49.09$392,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2016Steven M KloskCEOSell19,565$41.00$802,165.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Louis J GrabowskyDirectorBuy750$40.10$30,075.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016William B KorbDirectorSell8,000$41.38$331,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2016Gregory SargenCFOSell13,622$36.16$492,571.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2016Shawn CavanaghCOOSell18,342$36.13$662,696.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2016Steven M. KloskCEOSell39,542$36.20$1,431,420.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015Leon J. Hendrix, Jr.DirectorSell7,000$51.34$359,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Peter G. TombrosDirectorSell31,236$51.37$1,604,593.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/30/2015Ilan KaufthalDirectorSell52,315$54.32$2,841,750.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2015Gregory SargenCFOSell28,750$49.14$1,412,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Samantha HanleyVPSell15,000$52.03$780,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2015William B. KorbDirectorSell3,600$48.00$172,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2015Ilan KaufthalDirectorSell50,000$41.31$2,065,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2015Gregory SargenCFOSell25,000$38.44$961,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015Aldo MagniniDirectorSell7,500$32.75$245,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015Gregory SargenCFOSell25,000$32.64$816,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Steven M KloskCEOSell45,000$30.32$1,364,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2014Shawn CavanaghCOOSell56,251$22.56$1,269,022.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Steven M KloskCEOSell126,257$22.01$2,778,916.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014William M HaskelSVPSell9,400$21.94$206,236.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Steven M KloskCEOSell4,702$22.00$103,444.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Steven M KloskCEOSell1,200$22.52$27,024.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014William M HaskelSVPSell28,100$22.50$632,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Gregory SargenCFOSell50,000$22.34$1,117,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2014Leon Hendrix, Jr.DirectorSell23,000$20.09$462,070.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Aldo MagniniDirectorSell6,000$22.10$132,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2013Paolo RussoloInsiderSell35,000$18.40$644,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2013Gregory SargenCFOSell20,000$18.92$378,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2013John MillerDirectorSell2,000$19.21$38,420.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013Paolo RussoloInsiderSell32,903$12.53$412,274.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Leon J Hendrix JrDirectorSell1,120$13.40$15,008.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Cambrex (NYSE:CBM)
DateHeadline
06/30/16 10:55 AMCambrex Corporation (NYSE:CBM) Shorted Shares Decreased By 5.43% - Press Telegraph
06/28/16 02:25 PMTop Stock Pick for Quarter: Cambrex Corporation (NYSE:CBM) - Engelwood Daily
06/26/16 02:53 PMStock Performance Focus on: Cambrex Corporation (NYSE:CBM) - Press Telegraph
06/24/16 11:11 AMCambrex Corporation (NYSE:CBM) Updated Price Targets - FTSE News
06/22/16 07:51 AMCambrex Corporation (CBM) is Trading Higher on Unusual Volume for June 20 - Equities.com
06/22/16 07:51 AMCambrex Corporation (CBM) Jumps 5.11% on June 20 - Equities.com
06/22/16 07:51 AMTrade-Ideas: Cambrex (CBM) Is Today's "Perilous Reversal" Stock - TheStreet.com
06/21/16 02:59 PMRecently Issued Stock Ratings For Cambrex Corporation (NYSE:CBM) - Fiscal Standard
06/21/16 10:22 AMCambrex Corp. – Value Analysis (NYSE:CBM) : June 21, 2016 -
06/20/16 07:16 AMCambrex Corp. breached its 50 day moving average in a Bearish Manner : CBM-US : June 20, 2016 -
06/19/16 02:58 PMThis Weeks Broker Views For Cambrex Corporation (NYSE:CBM) - Fiscal Standard
06/16/16 03:30 PMU.S. Stocks End Slump As Dow Leads; Merck Gains, But Nike Falls -
06/13/16 02:33 PMChesapeake Energy Corporation (NYSE:CHK) Went Down-9.43%: Cambrex Corporation (NYSE:CBM), Sirius XM ... - KC Register
06/10/16 09:01 PMCambrex Corporation Common Stoc (NYSE:CBM) Trading Down - Insiders Are Buying and Selling - Finance Daily
06/09/16 10:32 AMCambrex Corporation (NYSE:CBM) Increased2.04%: Nevro Corp. (NYSE:NVRO), LGI Homes, Inc. (NASDAQ:LGIH ... - KC Register
06/06/16 08:30 PMCAMBREX CORPORATION (NYSE:CBM) Financial Condition Compared to S&P 500 - CML News
06/05/16 08:23 PMCambrex Corporation (NYSE:CBM) Sellers Covered 2.04% of Their Shorts - HNN
06/05/16 03:02 PMPerformance Review for Cambrex Corporation (NYSE:CBM) - HNN
06/03/16 11:42 AMCambrex Corporation (CBM) is Trading Higher on Unusual Volume for June 01 - Equities.com
06/03/16 10:25 AMCambrex to Present at the Jefferies 2016 Global Healthcare Conference - [at noodls] - EAST RUTHERFORD, N.J., June 03, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) ('Cambrex') is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the ...
06/02/16 09:08 PMActive Volatile Stocks- Cambrex (NYSE:CBM), ServiceNow (NYSE:NOW), J. C. Penney (NYSE:JCP) - Seneca Globe - Active Volatile Stocks- Cambrex (NYSE:CBM), ServiceNow (NYSE:NOW), J. C. Penney (NYSE:JCP)Seneca GlobeCambrex Corporation (NYSE:CBM) was amid the mix trends movers as shares ascend 4.62% to $51.17. CB Richard (CBG) Ellis takeoverd Michael Horwitz & Firm; terms not revealed. The firm has takeoverd Michael Horwitz & Firm, a London-based retail ...and more »
06/01/16 09:15 PMKeep me signed in - Investor's Business Daily - Investor's Business DailyKeep me signed inInvestor's Business DailyAmong IBD 50 stocks, 37 were higher and 13 were lower. The best performer was Cambrex (CBM), up about 5%. It broke out of a cup-with-handle base with a 47.03 buy point April 29. It touched a new high Wednesday as it moved out of a brief consolidation.and more »
06/01/16 03:46 PMStocks Up Modestly; Medical Products Maker Cambrex Leads IBD 50 - Stocks overcame early weakness to finish mildly higher Wednesday.
06/01/16 12:37 PMStocks Near Flat Line In Afternoon; IBD 50 Name Cambrex Soars - After a soft open, stocks recovered a bit in afternoon trading Wednesday, helped by a better-than-expected U.S. manufacturing data.
06/01/16 11:19 AMStocks Flat At Midday; GM, Ford Hit By Weak Auto Sales -
05/30/16 12:46 PMNext Weeks Broker Price Targets For Cambrex Corporation (NYSE:CBM) - Share Trading News - Next Weeks Broker Price Targets For Cambrex Corporation (NYSE:CBM)Share Trading NewsCambrex Corporation has a 50 day moving average of 46.53 and a 200 day moving average of 44.37. The stock's market capitalization is 1.56B, it has a 52-week low of 29.50 and a 52-week high of 55.60. The share price of the company (NYSE:CBM) was ...and more »
05/28/16 10:46 AMCambrex Corporation (NYSE:CBM) Shorted Shares Decreased By 2.04% - HNN - Cambrex Corporation (NYSE:CBM) Shorted Shares Decreased By 2.04%HNNThe stock of Cambrex Corporation (NYSE:CBM) registered a decrease of 2.04% in short interest. CBM's total short interest was 1.96M shares in May as published by FINRA. Its down 2.04% from 2.01M shares, reported previously. With 462,200 shares ...and more »
05/23/16 07:44 AMBRIEF-Cambrex Corp says Co, subsidiary borrowers and guarantors entered into a credit agreement - * On may 18, 2016, cambrex corp, subsidiary borrowers party thereto and subsidiary guarantors party thereto entered into a credit agreement
05/23/16 06:06 AMCambrex Announces Closing of New $500 Million Senior Credit Facility - [at noodls] - EAST RUTHERFORD, N.J., May 23, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) ('Cambrex') is pleased to announce that the Company has closed a new $500 million senior secured revolving credit ...
05/23/16 05:48 AMCAMBREX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agr -
05/16/16 11:12 AMCambrex to Present at UBS Global Healthcare Conference - [at noodls] - EAST RUTHERFORD, N.J., May 16, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) ('Cambrex') is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the UBS ...
05/09/16 02:02 PMETF’s with exposure to Cambrex Corp. : May 9, 2016 -
05/05/16 12:04 PMCAMBREX CORP Financials -
05/04/16 10:32 AMCambrex Corp. :CBM-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/29/16 06:40 PMCambrex posts 1Q profit -
04/29/16 12:51 PMGilead Stock: Analyzing 5 Key Suppliers (GILD) -
04/29/16 10:52 AMEdited Transcript of CBM earnings conference call or presentation 29-Apr-16 12:30pm GMT -
04/29/16 06:31 AMCambrex Reports First Quarter 2016 Financial Results - [at noodls] - - Sales increased 20% and EBITDA increased 52% vs. prior year quarter - - 2016 financial guidance reaffirmed - - Conference call at 8:30 a.m. ET on April 29, 2016 - EAST RUTHERFORD, N.J., April 29, 2016 ...
04/29/16 06:14 AMCAMBREX CORP Files SEC form 10-Q, Quarterly Report -
04/29/16 06:07 AMQ1 2016 Cambrex Corp Earnings Release - Before Market Open -
04/27/16 09:55 AMCambrex to Present at the Deutsche Bank 41st Annual Health Care Conference - [at noodls] - EAST RUTHERFORD, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) ('Cambrex') is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the ...
04/26/16 09:55 AMCambrex to Announce First Quarter 2016 Financial Results on April 29, 2016 - [at noodls] - EAST RUTHERFORD, N.J., April 26, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) announced that first quarter 2016 financial results will be released on Friday, April 29, 2016 before the market ...
04/22/16 03:02 PMCAMBREX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
04/02/16 01:33 PMCambrex Corp (NYSE:CBM) Healthcare Sector Stock Business Summary - Street Report - Cambrex Corp (NYSE:CBM) Healthcare Sector Stock Business SummaryStreet Report[EDGAR] Cambrex Corp (NYSE:CBM)(TREND ANALYSIS) the Board of Directors of Cambrex Corporation appointed Claes Glassell, 65, as a member of the Company's Board of Directors for a term expiring on the date of its 2016 annual meeting and will ...Update: Cambrex Corp. was rated by Sidoti to InitiateThe Duncan Independent (press release) (blog)all 2 news articles »
03/16/16 06:30 AMClaes Glassell Appointed to the Board of Directors of Cambrex Corporation - [GlobeNewswire] - EAST RUTHERFORD, N.J., March 16, 2016-- Cambrex Corporation announced today that on March 14, 2016, Claes Glassell was appointed to the Company’ s Board of Directors for a term expiring on the date of ...
03/08/16 09:09 AMCan The Uptrend Continue for Cambrex (CBM)? -
03/04/16 07:40 AMCan Cambrex (CBM) Run Higher on Strong Earnings Estimate Revisions? -
03/03/16 07:19 AMCambrex Corp. breached its 50 day moving average in a Bullish Manner : CBM-US : March 3, 2016 -
03/01/16 08:19 AMIs Cambrex Corporation (CBM) a Great Growth Stock? -
02/26/16 07:57 AMCurrent Price Targets On Cambrex Corporation (NYSE:CBM) - Risers & Fallers - Current Price Targets On Cambrex Corporation (NYSE:CBM)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Cambrex Corporation (NYSE:CBM). The latest broker reports which are currently outstanding on Friday 26th of February state 3 analysts have a rating of “strong buy”, ...and more »
About Cambrex

Cambrex logoCambrex Corporation (Cambrex) is a life sciences company. The Company provides products and services for the development and commercialization of new and generic therapeutics. The Company supplies its products and services across the world to generic pharmaceutical companies. Cambrex operates through three segments, which are manufacturing facilities. The Company's manufacturing facilities are located in the Europe and the United States. The Company's business consists of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. The Company's products include active pharmaceutical ingredients (APIs), pharmaceutical intermediates and other fine chemicals. The Company's products and services are sold around the world under trademarks that are owned by the Company. This includes Profarmaco, which is registered around the world as a word and design mark. Its products are sold through a combination of direct sales and independent agents.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NYSE
  • Symbol: CBM
  • CUSIP: 13201110
Key Metrics:
  • Previous Close: $51.73
  • 50 Day Moving Average: $49.38
  • 200 Day Moving Average: $44.22
  • P/E Ratio: 26.50
  • P/E Growth: 1.32
  • Market Cap: $1.65B
  • Current Quarter EPS Consensus Estimate: $2.56 EPS
Additional Links:
Cambrex (NYSE:CBM) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha